MY116384A - Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it. - Google Patents

Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it.

Info

Publication number
MY116384A
MY116384A MYPI9503727A MY116384A MY 116384 A MY116384 A MY 116384A MY PI9503727 A MYPI9503727 A MY PI9503727A MY 116384 A MY116384 A MY 116384A
Authority
MY
Malaysia
Prior art keywords
low
dna
molecular dna
pharmaceutical preparation
molecular
Prior art date
Application number
Inventor
Alexandr Vilenovich Asafov
Eleonora Rafailovna Pereverzeva
Anatoly Borisovich Syrkin
Viktor Vladimirovich Ilyashenko
Natalya Alexandrovna Susuleva
Lev Abramovich Durnov
Olga Borisovna Zobova
Irina Lazarevna Kazarova
Nelli Borisovna Koroleva
Stepan Vazgenovich Kirakosian
Lidia Vasilievna Simonova
Vyacheslav Vladimirovich Bezjulev
Ljudmila Vasilievna Simonova
Larisa Alexandrovna Tarasova
Idia Grigorievna Anosova
Alexandr Andreevich Konarev
Igor Nikolaevich Karpov
Marina Gavrilovna Kochetkova
Ivan Dmitrievich Treschalin
Dmitry Alexandrovich Bodyagin
Elena Mikhailovna Treschalina
Original Assignee
Obschestvo S Orgranichennoi Otvetstvennostiju Np Predpr Farmek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obschestvo S Orgranichennoi Otvetstvennostiju Np Predpr Farmek filed Critical Obschestvo S Orgranichennoi Otvetstvennostiju Np Predpr Farmek
Priority to MYPI9503727 priority Critical patent/MY116384A/en
Publication of MY116384A publication Critical patent/MY116384A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

THE PRESENT INVENTION RELATES TO LOW-MOLECULAR DNA EXTRACTED FROM STURGEON MILT AND TO A PHARMACEUTICAL PREPARATION ON ITS BASE. THE INVENTION ALSO DISCLOSES A METHOD FOR PREPARATION OF LOW-MOLECULAR DNA FROM STURGEON MILT. A DESCRIPTION IS GIVEN OF A NEW PREPARATION BASED ON LOW-MOLECULAR DNA FOR USE IN THE CAPACITY OF A HEMOCORRECTOR, INHIBITOR OF VIRAL ACTIVITY, PARTICULARLY HIV INFECTION, AND FOR TREATING LESIONS OF THE MUCOUS MEMBRANE OF DIFFERENT ETIOLOGIES. ALSO DISCLOSED IS THE USE OF LOW-MOLECULAR DNA AS A UNIVERSAL COSMETIC ADDITION.
MYPI9503727 1995-12-02 1995-12-02 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it. MY116384A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI9503727 MY116384A (en) 1995-12-02 1995-12-02 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI9503727 MY116384A (en) 1995-12-02 1995-12-02 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it.

Publications (1)

Publication Number Publication Date
MY116384A true MY116384A (en) 2004-01-31

Family

ID=46850145

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI9503727 MY116384A (en) 1995-12-02 1995-12-02 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it.

Country Status (1)

Country Link
MY (1) MY116384A (en)

Similar Documents

Publication Publication Date Title
DE69627690D1 (en) LIPOSOMAL FORMULATIONS OF MITOXANTRON
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
IE900854L (en) Immunogenic regions on the E7 protein of human¹papillomavirus type 16
EP2292771A3 (en) Sense mRNA therapy
BG101130A (en) Inhibitors of interleukin-1-converting enzyme
ATE269711T1 (en) FORMULATION FOR USE IN THE PREVENTION OF PATHOGEN-INDUCED DISEASES, INCLUDING HIV AND HSV
WO1995021601A3 (en) Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
CA2165821A1 (en) Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection
DE69635933D1 (en) Electrosurgical removal of tissues
MX9704030A (en) 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
TR199802441A3 (en) Method and composition for the treatment and prevention of the presence of excess uric acid in the blood.
AU6584994A (en) Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
IL161177A0 (en) Pharmaceutical preparation useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
EP1239034A3 (en) Large circular target-specific antisense nucleic acids
HUP0001693A2 (en) Use of low molecular oligomer esters of alpha-hydroxy acids and/or aromatic of 0-hydroxy acids in cosmetic formulations
KR100725637B1 (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein
FR2751876B1 (en) USE OF AN OLIGOSACCHARIDE AS AN IMMUNOMODULATOR, DERMATO-COSMETIC COMPOSITION AND METHOD OF COSMETIC TREATMENT
PL338673A1 (en) Application of fanquinone in treating alzheimer disease
AR005750A1 (en) PHARMACEUTICAL COMPOSITION TO TREAT OR PREVENT ZOSTER INFECTIONS IN PERSONS INFECTED WITH THE VARICELA ZOSTER VIRUS AND PROCEDURE FOR PREPARING SUCH COMPOSITION
PT888114E (en) USING (+) - ALPHA- (2,3-DIMETOXYPHENYL) -1- [2- (4-FLUOROPHENYL) ETHYL] -4-PIPERIDINOMETHANOL IN THE TREATMENT OF DEPRESSIVE DISEASES AND BIPOLAR DISEASES
MY116384A (en) Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it.
WO1996039501A3 (en) Oligonucleotides specific for human papillomavirus
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
ATE238796T1 (en) NUCLEOSIDE DERIVATIVES IN COMBINATION PREPARATIONS FOR THE TREATMENT OF HSV DISEASES
WO1999021005A3 (en) Pharmaceutical grade st. john's wort